Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Function and control of recombination-activating gene activity.

Alt FW, Rathbun G, Oltz E, Taccioli G, Shinkai Y.

Ann N Y Acad Sci. 1992 May 4;651:277-94. Review.

PMID:
1599127
2.

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM, et al.

Cell. 1992 Mar 6;68(5):855-67.

PMID:
1547487
4.
5.

Expression of recombination activating genes (RAG-1 and RAG-2) in Epstein-Barr virus-bearing B cells.

Kuhn-Hallek I, Sage DR, Stein L, Groelle H, Fingeroth JD.

Blood. 1995 Mar 1;85(5):1289-99.

6.

Immunoglobulin gene hypermutation in germinal centers is independent of the RAG-1 V(D)J recombinase.

Zheng B, Han S, Spanopoulou E, Kelsoe G.

Immunol Rev. 1998 Apr;162:133-41. Review.

PMID:
9602359
7.

RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination.

Oettinger MA, Schatz DG, Gorka C, Baltimore D.

Science. 1990 Jun 22;248(4962):1517-23.

PMID:
2360047
9.

Comparison of RAG gene expression in normal and transformed precursor lymphocytes.

Rathbun G, Oltz EM, Alt FW.

Int Immunol. 1993 Aug;5(8):997-1000.

PMID:
8398992
10.

Chromatin structure and transcriptional regulation of human RAG-1 gene.

Kitagawa T, Mori K, Kishi H, Tagoh H, Nagata T, Kurioka H, Muraguchi A.

Blood. 1996 Nov 15;88(10):3785-91.

11.

Characterization of chromatin structure and enhancer elements for murine recombination activating gene-2.

Wei XC, Kishi H, Jin ZX, Zhao WP, Kondo S, Matsuda T, Saito S, Muraguchi A.

J Immunol. 2002 Jul 15;169(2):873-81.

12.

The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.

Noordzij JG, de Bruin-Versteeg S, Verkaik NS, Vossen JM, de Groot R, Bernatowska E, Langerak AW, van Gent DC, van Dongen JJ.

Blood. 2002 Sep 15;100(6):2145-52.

13.

RAG-1-deficient mice have no mature B and T lymphocytes.

Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE.

Cell. 1992 Mar 6;68(5):869-77.

PMID:
1547488
14.

A V(D)J recombinase-inducible B-cell line: role of transcriptional enhancer elements in directing V(D)J recombination.

Oltz EM, Alt FW, Lin WC, Chen J, Taccioli G, Desiderio S, Rathbun G.

Mol Cell Biol. 1993 Oct;13(10):6223-30.

15.
16.

Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.

Williams CJ, Grandal I, Vesprini DJ, Wojtyra U, Danska JS, Guidos CJ.

Mol Cell Biol. 2001 Jan;21(2):400-13.

17.

The V(D)J recombination activating gene, RAG-1.

Schatz DG, Oettinger MA, Baltimore D.

Cell. 1989 Dec 22;59(6):1035-48.

PMID:
2598259
18.

RAG-1 and RAG-2 gene expression and V(D)J recombinase activity are enhanced by protein phosphatase 1 and 2A inhibition in lymphocyte cell lines.

Casillas AM, Thompson AD, Cheshier S, Hernandez S, Aguilera RJ.

Mol Immunol. 1995 Feb;32(3):167-75.

PMID:
7898493
19.

A regulatory role for recombinase activating genes, RAG-1 and RAG-2, in T cell development.

Wayne J, Suh H, Misulovin Z, Sokol KA, Inaba K, Nussenzweig MC.

Immunity. 1994 May;1(2):95-107.

PMID:
7534201
20.

Regulation of RAG expression in developing lymphocytes.

Nagaoka H, Yu W, Nussenzweig MC.

Curr Opin Immunol. 2000 Apr;12(2):187-90. Review.

PMID:
10712943

Supplemental Content

Support Center